Can You Combine IVM with ICSI for Male Factor Infertility?

Male factor infertility affects roughly half of all couples struggling to conceive, and for many, intracytoplasmic sperm injection offers a reliable solution. However, when ICSI is necessary, traditional IVF requires intensive hormone stimulation, which can be physically demanding and expensive. This raises an important question for couples facing both sperm-related challenges and concerns about ovarian stimulation: is there a way to address male factor infertility without the burden of daily injections?

The good news is that in vitro maturation can indeed be combined with ICSI, offering a gentler approach to fertility treatment. At Chedid Grieco, this combination represents a significant advancement for couples dealing with male infertility, eliminating the need for 10 to 12 days of ovarian stimulation while still addressing sperm quality concerns. For couples who have postponed treatment due to the medication burden, this pairing provides a pathway forward without compromising success rates.

Understanding IVM and ICSI as Complementary Techniques

IVM retrieves immature eggs from the ovaries without hormonal stimulation and matures them in a laboratory setting over 24 to 48 hours. This contrasts with conventional IVF, which requires daily hormone injections to stimulate egg development before retrieval. The eggs mature naturally in the lab, eliminating medication side effects and reducing treatment costs.

Intracytoplasmic sperm injection addresses fertilization challenges by injecting a single sperm directly into each mature egg. This technique bypasses natural fertilization barriers and proves particularly effective when sperm count is low, motility is compromised, or morphology is abnormal. ICSI also works well in cases where previous IVF cycles showed poor fertilization rates.

When combined, these techniques address two distinct fertility challenges simultaneously. IVM provides mature eggs without stimulation protocols, while ICSI ensures successful fertilization regardless of sperm parameters. This pairing creates a streamlined treatment option that reduces physical strain and medication exposure.

When Combining IVM and ICSI Makes Sense

Several specific situations make this combined approach particularly beneficial for couples facing both ovarian stimulation concerns and male factor infertility challenges.

Couples With Dual Fertility Factors

Men with low sperm count, poor motility, or abnormal morphology benefit from ICSI’s direct injection method. When their partners also face concerns about ovarian stimulation, IVM becomes a practical alternative. This combination works particularly well for couples who have experienced medication side effects in previous cycles or those with limited budgets for fertility treatment.

Polycystic Ovary Syndrome Patients

Women with PCOS face heightened risks during traditional IVF stimulation, including ovarian hyperstimulation syndrome. According to research published by the National Institutes of Health, women with PCOS experience significantly elevated risks of OHSS during conventional ovarian stimulation. IVM eliminates this risk entirely by removing hormonal stimulation from the equation, while ICSI ensures fertilization proceeds normally despite any male factor involvement.

Previous Poor Responders to Stimulation

Some women produce few eggs even with maximum hormone dosages, making traditional IVF frustrating and expensive. These poor responders may achieve comparable results with IVM while avoiding the disappointment of minimal egg retrieval after extensive stimulation. When paired with ICSI for male factor concerns, this approach provides results without the protocol adjustments and repeated medication failures.

The IVM-ICSI Treatment Process

The combined procedure begins with minimal or no hormone stimulation, followed by egg retrieval when follicles measure 8 to 12 millimeters. Retrieved immature eggs then transfer to a specially formulated culture medium containing growth factors and hormones that support natural maturation. Laboratory specialists monitor development closely, assessing maturity at 24-hour intervals.

Once eggs reach maturity, embryologists perform ICSI by selecting the healthiest sperm and injecting it directly into each egg’s cytoplasm. Fertilization typically occurs within 18 hours, and embryos develop over the following three to five days. Key steps in the combined treatment include:

• Egg retrieval with minimal stimulation protocols
• Laboratory maturation of immature eggs over 24 to 48 hours
• ICSI procedure using the healthiest available sperm
• Embryo development and quality assessment over three to five days
• Transfer of the highest-quality embryos to the uterus

Recovery from IVM procedures typically involves less discomfort than traditional IVF because minimal hormonal stimulation means reduced bloating and no OHSS risk. Patients generally resume normal activities within a day or two, though they should avoid strenuous exercise until after embryo transfer.

Success Rates and Realistic Expectations

IVM combined with ICSI yields pregnancy rates comparable to traditional IVF with ICSI for appropriate candidates, though outcomes vary based on age, egg quality, and overall reproductive health. Younger patients with good ovarian reserve typically see the highest success rates, while women over 38 may require multiple cycles to achieve pregnancy. The maturation rate for retrieved immature eggs ranges from 50 to 80 percent, meaning not every collected egg will successfully mature in the laboratory.

Fertilization rates following ICSI remain consistent regardless of whether eggs matured naturally in the ovaries or in vitro. This consistency makes the combination particularly appealing for couples addressing male factor infertility. Multiple embryo transfers may still be necessary, and couples should discuss realistic timelines with their fertility specialists.

Cost and Practical Considerations

The financial advantages of IVM prove substantial, as eliminating expensive hormone medications reduces overall treatment costs by 30 to 50 percent compared to traditional IVF. This makes fertility treatment more accessible for couples without insurance coverage or those paying out-of-pocket for care. The reduced medication burden also means fewer monitoring appointments and blood tests, further decreasing both time and financial investment.

For international patients considering fertility tourism, IVM combined with ICSI offers additional savings without compromising care quality. The simplified medication protocol makes treatment coordination easier across borders, and shorter stimulation phases mean fewer travel days. Couples can complete treatment more efficiently while accessing FDA-licensed facilities that maintain rigorous standards.

Begin Your Fertility Journey With Chedid Grieco

Combining IVM with ICSI eliminates the traditional barriers many couples face when addressing both male factor infertility and concerns about intensive hormone protocols. With nearly 9,000 babies born through advanced reproductive techniques and 30 years of specialized experience, Chedid Grieco provides personalized treatment plans that prioritize your comfort and success. Our FDA-licensed and NYDH-licensed facility in São Paulo operates with the same rigorous standards required in the United States, while our multilingual team supports you in English, Spanish, Portuguese, or French. Consultations are conveniently held in Miami, with treatments conducted in Brazil, offering you boutique care and significant cost savings. Contact our office to learn how this innovative combination can help you achieve your family-building goals.